|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Supportive care
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
METC 191.137/2000/088 NCT00263315
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care
|
|
|
|
Completed
|
|
|
|
2 to 80
|
|
|
|
NCI
|
|
|
|
NCI-95-C-0131A
|
|
|
|
|
|
|
|
Last Modified: 9/1/1999  First Published: 5/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care
|
|
|
|
Completed
|
|
|
|
12 and over
|
|
|
|
NCI, Pharmaceutical / Industry
|
|
|
|
NCI-98-C-0063 PFIZER-150-603
|
|
|
|
|
|
|
|
Last Modified: 5/21/2007  First Published: 6/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care
|
|
|
|
Closed
|
|
|
|
15 and over
|
|
|
|
|
|
|
|
MRC-LEUK-IFI EU-97030, NCT00003315
|
|
|
|
|
|
|
|
Last Modified: 7/11/2007  First Published: 8/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care
|
|
|
|
Closed
|
|
|
|
Not specified
|
|
|
|
Other
|
|
|
|
EORTC-19951 NCT00003938
|
|
|
|
|
|
|
|
Last Modified: 7/11/2007  First Published: 1/1/2001 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care
|
|
|
|
Closed
|
|
|
|
16 and over
|
|
|
|
NCI, Pharmaceutical / Industry
|
|
|
|
MSKCC-00085 MERCK-026-01, NCI-G00-1898, NCT00008359
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Supportive care
|
|
|
|
Closed
|
|
|
|
1 to 17
|
|
|
|
NCI
|
|
|
|
NCI-97-C-0013
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Supportive care
|
|
|
|
Completed
|
|
|
|
2 to 18
|
|
|
|
NCI
|
|
|
|
NCI-92-C-0047B NCI-T92-0001N, T92-0001
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Supportive care
|
|
|
|
Completed
|
|
|
|
2 to 17
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
2004_101 Formerly-0404ETPP, MK0991-044, NCT00082537
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Supportive care
|
|
|
|
Completed
|
|
|
|
13 to 80
|
|
|
|
|
|
|
|
NCI-94-C-0120D
|
|
|
|